COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers

Marcus Messmer; Nina Wagner-Johnston

doi:10.1080/10428194.2021.1941939

COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	3019-3022
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	62
Issue number	12
DOIs	https://doi.org/10.1080/10428194.2021.1941939
State	Published - 2021

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2021.1941939

Cite this

@article{67478a77bef247cc8e6e6ba93684186f,

title = "COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers",

author = "Marcus Messmer and Nina Wagner-Johnston",

note = "Funding Information: The authors wish to thank their colleagues from NCI-designated cancer centers who participated in the survey.",

year = "2021",

doi = "10.1080/10428194.2021.1941939",

language = "English (US)",

volume = "62",

pages = "3019--3022",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "12",

}

TY - JOUR

T1 - COVID-19 vaccination in patients on rituximab

T2 - a survey of lymphoma physicians at NCI designated cancer centers

AU - Messmer, Marcus

AU - Wagner-Johnston, Nina

N1 - Funding Information: The authors wish to thank their colleagues from NCI-designated cancer centers who participated in the survey.

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85108620129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108620129&partnerID=8YFLogxK

U2 - 10.1080/10428194.2021.1941939

DO - 10.1080/10428194.2021.1941939

M3 - Letter

C2 - 34151698

AN - SCOPUS:85108620129

SN - 1042-8194

VL - 62

SP - 3019

EP - 3022

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 12

ER -

COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this